Skip to main content
NCBI home page
The BMJ logoLink to The BMJ
. 1992 Sep 5;305(6853):548–553. doi: 10.1136/bmj.305.6853.548

Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners: Grampian region early anistreplase trial. GREAT Group.

PMCID: PMC1883310  PMID: 1393033

Abstract

OBJECTIVE--To assess the feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners. DESIGN--Randomised double blind parallel group trial of anistreplase 30 units intravenously and placebo given either at home or in hospital. SETTING--29 rural practices in Grampian admitting patients to teaching hospitals in Aberdeen (average distance 36 (range 16-62) miles). PATIENTS--311 patients with suspected acute myocardial infarction and no contraindications to thrombolytic therapy seen at home within four hours of onset of symptoms. MAIN OUTCOME MEASURES--Time saving, adverse events, Q wave infarction, left ventricular function. RESULTS--Anistreplase was administered at home 101 minutes after onset of symptoms, while anistreplase was given in hospital 240 minutes after onset of symptoms (median times). Adverse events after thrombolysis were infrequent and, apart from cardiac arrest, not a serious problem when they occurred in the community: seven of 13 patients were resuscitated after cardiac arrest out of hospital. By three months after trial entry the relative reduction of deaths from all causes in patients given thrombolytic therapy at home was 49% (13/163 (8.0%) v 23/148 (15.5%); difference -7.6% (95% confidence interval -14.7% to -0.4%), p = 0.04). Full thickness Q wave infarction was less common in patients with confirmed infarction receiving treatment at home (65/122 (53.3%) v 76/112 (67.9%); difference -14.6% (95% confidence interval -27.0% to -2.2%), p = 0.02). CONCLUSIONS--General practitioners provided rapid pre-hospital coronary care of a high standard. Compared with later administration in hospital, giving anistreplase at home resulted in reduction in mortality, fewer cardiac arrests, fewer Q wave infarcts, and better left ventricular function. Benefits were most marked where thrombolytic therapy was administered within two hours of the onset of symptoms.

Full text

PDF
548

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bergmann S. R., Lerch R. A., Fox K. A., Ludbrook P. A., Welch M. J., Ter-Pogossian M. M., Sobel B. E. Temporal dependence of beneficial effects of coronary thrombolysis characterized by positron tomography. Am J Med. 1982 Oct;73(4):573–581. doi: 10.1016/0002-9343(82)90338-2. [DOI] [PubMed] [Google Scholar]
  2. Cobbe S. M., Redmond M. J., Watson J. M., Hollingworth J., Carrington D. J. "Heartstart Scotland"--initial experience of a national scheme for out of hospital defibrillation. BMJ. 1991 Jun 22;302(6791):1517–1520. doi: 10.1136/bmj.302.6791.1517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Colquhoun M. C., Julian D. G. Treatable arrhythmias in cardiac arrests seen outside hospital. Lancet. 1992 May 9;339(8802):1167–1167. doi: 10.1016/0140-6736(92)90765-u. [DOI] [PubMed] [Google Scholar]
  4. Crampton R. S., Aldrich R. F., Gascho J. A., Miles J. R., Jr, Stillerman R. Reduction of prehospital, ambulance and community coronary death rates by the community-wide emergency cardiac care system. Am J Med. 1975 Feb;58(2):151–165. doi: 10.1016/0002-9343(75)90564-1. [DOI] [PubMed] [Google Scholar]
  5. Haites N. E., McLennan F. M., Mowat D. H., Rawles J. M. Assessment of cardiac output by the Doppler ultrasound technique alone. Br Heart J. 1985 Feb;53(2):123–129. doi: 10.1136/hrt.53.2.123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Maclennan A. C., Ahmad N., Lawrence J. R. Activities of aminotransferases after treatment with streptokinase for acute myocardial infarction. BMJ. 1990 Aug 11;301(6747):321–322. doi: 10.1136/bmj.301.6747.321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Mathewson Z. M., McCloskey B. G., Evans A. E., Russell C. J., Wilson C. Mobile coronary care and community mortality from myocardial infarction. Lancet. 1985 Feb 23;1(8426):441–444. doi: 10.1016/s0140-6736(85)91156-0. [DOI] [PubMed] [Google Scholar]
  8. Metcalfe M. J., Rawles J. M., Shirreffs C., Jennings K. Six year follow up of a consecutive series of patients presenting to the coronary care unit with acute chest pain: prognostic importance of the electrocardiogram. Br Heart J. 1990 May;63(5):267–272. doi: 10.1136/hrt.63.5.267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Metcalfe M. J., Rawles J. M. Stroke distance in acute myocardial infarction: a simple measurement of left ventricular function. Lancet. 1989 Jun 17;1(8651):1371–1373. doi: 10.1016/s0140-6736(89)92814-6. [DOI] [PubMed] [Google Scholar]
  10. Pai G. R., Haites N. E., Rawles J. M. One thousand heart attacks in Grampian: the place of cardiopulmonary resuscitation in general practice. Br Med J (Clin Res Ed) 1987 Feb 7;294(6568):352–354. doi: 10.1136/bmj.294.6568.352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Pantridge J. F., Geddes J. S. A mobile intensive-care unit in the management of myocardial infarction. Lancet. 1967 Aug 5;2(7510):271–273. doi: 10.1016/s0140-6736(67)90110-9. [DOI] [PubMed] [Google Scholar]
  12. Petch M. C. Coronary thrombolytic treatment at home. BMJ. 1991 Jun 1;302(6788):1287–1288. doi: 10.1136/bmj.302.6788.1287. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Rawles J. M. General practitioners' management of acute myocardial infarction and cardiac arrest: relevance to thrombolytic treatment. Br Med J (Clin Res Ed) 1987 Sep 12;295(6599):639–640. doi: 10.1136/bmj.295.6599.639. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Rawles J. M., Haites N. E. Patient and general practitioner delays in acute myocardial infarction. Br Med J (Clin Res Ed) 1988 Mar 26;296(6626):882–884. doi: 10.1136/bmj.296.6626.882. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Rowley J. M., Mounser P., Harrison E. A., Skene A. M., Hampton J. R. Management of myocardial infarction: implications for current policy derived from the Nottingham Heart Attack Register. Br Heart J. 1992 Mar;67(3):255–262. doi: 10.1136/hrt.67.3.255. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Shah M., Taylor R. T. Low back pain associated with streptokinase. BMJ. 1990 Nov 24;301(6762):1219–1219. doi: 10.1136/bmj.301.6762.1219-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Wennerblom B., Holmberg S., Wedel H. The effect of a mobile coronary care unit on mortality in patients with acute myocardial infarction or cardiac arrest outside hospital. Eur Heart J. 1982 Dec;3(6):504–515. doi: 10.1093/oxfordjournals.eurheartj.a061345. [DOI] [PubMed] [Google Scholar]
  18. Wilcox R. G., von der Lippe G., Olsson C. G., Jensen G., Skene A. M., Hampton J. R. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet. 1988 Sep 3;2(8610):525–530. doi: 10.1016/s0140-6736(88)92656-6. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES